Streetbeat News

Products Services

VTAK

Catheter Precision, Inc. (NYSE:VTAK), a US-based medical device company, has signed a distribution agreement with Supri Artigos Medico Hospitalares Ltda for its electrophysiology product, LockeT, in Brazil. This marks the company's first distributor in South America, aiming to provide innovative technologies to improve patient care and workflow efficiency in a cost-effective manner.

Portfolio Pulse from Benzinga Newsdesk

January 22, 2024 | 1:09 pm

SYTA

Siyata Mobile Inc. has expanded its dealer network by partnering with CTS Mobility, a large Verizon Elite Partner. CTS Mobility will distribute Siyata's SD7 Push-to-Talk over Cellular handsets and accessories. This partnership aims to enhance the distribution of Siyata's products across the United States and internationally, leveraging CTS Mobility's commitment to providing best-in-class outcomes for its customers, including enterprises and emergency management services.

Portfolio Pulse from Benzinga Newsdesk

January 22, 2024 | 1:08 pm

OPXS

Optex Systems Holdings, Inc. (NASDAQ:OPXS) has acquired Speedtracker from RUB Aluminum and entered into a Contract Manufacturing Agreement to continue producing the Speedtracker Mach 4+ product line. The acquisition was made with cash on hand and may include future payments based on milestones. Speedtracker is a radar-based chronograph for measuring projectile velocity, and Optex aims to expand its distribution and growth. No financial terms were disclosed.

Portfolio Pulse from Benzinga Newsdesk

January 22, 2024 | 1:04 pm

ESTA

Establishment Labs has launched its Motiva Implants in China, targeting the plastic and reconstructive surgery market. This expansion into the Chinese market represents a significant step for the company as it taps into one of the largest markets for cosmetic surgery.

Portfolio Pulse from Benzinga Newsdesk

January 22, 2024 | 1:03 pm

SXTP

60 Degrees Pharmaceuticals will proceed with a pivotal clinical study of Tafenoquine for hospitalized Babesiosis patients in the U.S. after a Type C meeting with the FDA.

Portfolio Pulse from Benzinga Newsdesk

January 22, 2024 | 1:01 pm

MRKR

Marker Therapeutics, Inc. has received approval for the nonproprietary name 'Neldaleucel' for its product MT-601 from the United States Adopted Name Council and the International Nonproprietary Names Expert Committee. This marks a step forward in the development and potential commercialization of MT-601.

Portfolio Pulse from Benzinga Newsdesk

January 22, 2024 | 12:46 pm

NUKK

Nukkleus Inc. (NASDAQ:NUKK) and its subsidiary, Digital RFQ (DRFQ), have announced a collaboration with Tantel Group to expand in Africa's B2B payments market, valued at over $1.5 trillion. The partnership aims to improve cross-border payment efficiency, reduce costs, and enhance reliability in the region. Nukkleus's CEO emphasized the potential for increased transaction volume for DRFQ as a result of this initiative.

Portfolio Pulse from Benzinga Newsdesk

January 22, 2024 | 12:46 pm

SRDX

Surmodics has announced the early clinical use of its Pounce LP Thrombectomy System, which received FDA clearance in June 2023. The system is in limited market evaluation with a full commercial launch expected after the LME is completed.

Portfolio Pulse from Benzinga Newsdesk

January 22, 2024 | 12:41 pm

RVSN

Rail Vision announced that its Main Line System has successfully received formal certifications for key EU railway standards. Noam Shloper, Head of Quality and Reliability, stated this achievement positions the company ahead of its competitors in the railway technology market.

Portfolio Pulse from Benzinga Newsdesk

January 22, 2024 | 12:39 pm

APYX

Apyx Medical announced the publication of a peer-reviewed article in the Aesthetic Surgery Journal Open Forum. The article evaluated the use of Renuvion, a proprietary technology of Apyx Medical, for contracting subcutaneous soft tissue following liposuction in multiple areas of the body.

Portfolio Pulse from Benzinga Newsdesk

January 22, 2024 | 12:38 pm